Itinai.com light and shadow chase in a bright clinical trial 46d6fec8 e34f 4900 920c bc826aa5cb79 2
Itinai.com light and shadow chase in a bright clinical trial 46d6fec8 e34f 4900 920c bc826aa5cb79 2

Comparison of novel PSMA-targeting [177Lu]Lu-P17-087 with its albumin binding derivative [177Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human study

 Comparison of novel PSMA-targeting [<sup>177</sup>Lu]Lu-P17-087 with its albumin binding derivative [<sup>177</sup>Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human study” width=”500″ height=”auto” /></figure>
<p>“`html</p>
<h3>Study on PSMA-Targeting Radionuclide Therapy for Prostate Cancer</h3>
<h4>Purpose:</h4>
<ul>
<li>Assess PSMA-targeting radionuclide therapy for prostate cancer</li>
<li>Evaluate dosimetry and radiation toxicity</li>
<li>Explore PSA response in metastatic castration-resistant prostate cancer (mCRPC) patients</li>
</ul>
<h4>Methods:</h4>
<ul>
<li>Patients with PSMA-positive tumors enrolled after PET/CT scan</li>
<li>Five patients received [177Lu]Lu-P17-087 and four received [177Lu]Lu-P17-088</li>
<li>Imaging and dosimetry evaluations were performed for both patient groups</li>
</ul>
<h4>Results:</h4>
<ul>
<li>No major clinical side-effects observed with low dose treatment</li>
<li>[177Lu]Lu-P17-088 exhibited higher effective doses than [177Lu]Lu-P17-087</li>
<li>[177Lu]Lu-P17-087 demonstrated excellent tumor uptake and faster kinetics</li>
<li>[177Lu]Lu-P17-088 showed slower washout and higher average dose</li>
<li>Reduction in PSA values observed in patients receiving both agents</li>
</ul>
<h4>Conclusion:</h4>
<ul>
<li>[177Lu]Lu-P17-088 and [177Lu]Lu-P17-087 are promising for personalized treatment of mCRPC</li>
<li>Further studies are needed to evaluate potential therapeutic efficacy</li>
</ul>
<p>Find the trial registration <a href=here.

“`

AI-Powered Health Tools

Interactive AI Tools to Help You Understand Your Health

Solutions for Smart Healthcare

Clinical Research